Nutriband (NTRB) - חוב לטווח ארוך להון

The long-term credit leverage on the GURU.Markets chart illustrates borrowing dynamics, where 0.01 forms the current metric value. Production scaling challenges and dependence on FDA verdicts are constraining the growth of Nutriband Inc. (NTRB). However, demand for secure opioid delivery systems opens broad market prospects, reinforcing the image of Nutriband Inc. (NTRB) as a reliable developer of safe chronic pain therapy methods.

When assessing the financial resilience of Nutriband Inc. (NTRB) against market downturns, it is essential to consider the specifics of its capital expenditures. The development of overdose-resistant transdermal systems requires significant R&D investment. Analyzing the structure of long-term debt relative to equity allows for an assessment of the company's reliance on borrowed funds with maturities exceeding one year. A decrease in this ratio confirms successful deleveraging and a healthier balance sheet. Stable dynamics of this indicator guarantee the reliability of the business's fundamental base.